Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy

PARAMUS, N.J., Aug. 20, 2024 /PRNewswire/ — Octapharma USA has received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for its proprietary octaplasLG Powder (blood group types A and AB). The EUA allows U.S. Department of Defense medical providers to administer the…